Bravecto X-Large Dog 1400mg (40-56kg)

Bravecto (1400mg) is a chewable oral flea and tick treatment for dogs.



GENERAL INFORMATION
Bravecto contains fluralaner, a systemic insecticide and acaricide with a long duration of action 
that provides immediate and persistent tick (adult and juvenile Haemaphysalis longicornis (NZ 
Cattle Tick)) and flea (Ctenocephalides felis) killing activity for 12 weeks. 
Controlled trials indicate that directly after treatment, Bravecto kills 96.8% of existing ticks on the 
dog within 8 hours and 100% within 12 hours. At 12 weeks after treatment, around 97.1% of new 
ticks are killed within 12 hours.

Indications: 
For the control of tick and flea infestations on dogs for 12 weeks. 
• Treats and controls existing flea and tick infestations 
• Sustained control of new flea and tick infestations for 12 weeks 
• Safe for use in breeding, pregnant and lactating dogs 
• Aids in the control of flea allergy dermatitis 

Active Ingredients:  
Bravecto contains fluralaner.  

 

Dosage:
For oral use only. 
Bravecto chewable tablets should be administered in accordance with the following table (corresponding to a dose of 25-56 mg fluralaner/kg body weight within one weight band):  

Bodyweight (kg) of dog

Number and strength of tablet to be administered                      
  Bravecto    112.5 mg Bravecto 250 mg Bravecto 500 mg Bravecto 1000 mg Bravecto 1400 mg
2* - 4.5 1        
> 4.5 - 10   1      
> 10 - 20     1    
> 20 - 40       1  
> 40 - 56         1
*For use in dogs from 8 weeks of age only.


For optimal control of tick and flea infestation, the Bravecto chewable tablet should be administered at 12 week intervals. Bravecto chewable tablet can be administered all year round

 

ADMINISTRATION
Administer Bravecto chewable tablets at or around the time of feeding. Bravecto is a chewable 
tablet and is well accepted by most dogs. If the tablet is not taken up voluntarily by the dog it can 
also be given with food or placed directly into the mouth. 
To ensure a therapeutic dose is administered, the chewable tablets should not be broken or 
divided.
For optimal control of tick and flea infestation, the Bravecto chewable tablet should be 
administered at 12 week intervals. Bravecto chewable tablet can be administered all year round. 
 
CONTRAINDICATIONS
If hypersensitivity to the active substance or to any of the excipients is known or suspected, do not 
use this product. 
The safety has not been established in puppies less than 8 weeks old and/or dogs weighing 
less than 2 kg. The safety has not been established for treatment with this product when 
administered at intervals shorter than 8 weeks.
Please consult your veterinarian for advice before using Bravecto if your pet is receiving 
medication such as non-steroidal anti-inflammatory drugs (NSAIDs) or warfarin. Studies on 
Bravecto have shown no interactions with routinely used veterinary medicinal products. Fluralaner 
exhibits a high plasma protein binding capacity. In vitro studies have shown fluralaner to have no 
influence on the plasma protein binding capacity of carprofen and warfarin.
Safety has been demonstrated in breeding, pregnant and lactating animals treated with overdoses 
of up to 3 times the maximum recommended dose. Safety has been demonstrated in puppies 
aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum 
recommended dose on three occasions at shorter intervals than recommended (8-week intervals). 
The product was well tolerated in MDR1-deficient Collies following single oral administration at 3 
times the recommended dose. 
 
ADVERSE REACTIONS
Mild and transient gastrointestinal symptoms such as diarrhoea/ vomiting/ inappetence/ drooling 
related to the route of administration of the product may be observed. If you notice any serious 
effects or other effects not mentioned in this leaflet, please inform your veterinarian.

 

No Reviews Yet!

Be the first by logging in here!